Olgu Sunumu
BibTex RIS Kaynak Göster

Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity

Yıl 2014, Cilt: 27 Sayı: 2, 129 - 131, 20.05.2014

Öz

Mastoid region recurrence is a rare entity for nasopharyngeal
cancer. This paper presents a patient with an isolated mastoid
recurrence following definitive treatment and discusses the
therapeutic approach which may help in the treatment of such cases.

Kaynakça

  • 1. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012;22:233-44. doi:10.1016/j. semradonc.2012.03.008
  • 2. Atasoy BM, Ozyar E, Akman F, Esassolak M, Abacioğlu U. T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology? Kulak Burun Bogaz Ihtis Derg 2010;20:89-96.
  • 3. Atasoy BM, Dane F, Yumuk PF, et al. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma. J BUON 2008;13:43-50.
  • 4. Zhang X, Luo J, Gao L, Xu G. Mastoid recurrence after radiotherapy for nasopharyngeal carcinoma: two case studies. Head Neck 2011;33:1535-8. doi: 10.1002/hed.21391
  • 5. Yang MS, Chen CC, Cheng YY, et al. Nasopharyngeal carcinoma spreading along the eustachian tube: the imaging appearance. J Chin Med Assoc 2004;67:200-3.
  • 6. Dubrulle F, Souillard R, Hermans R. Extension patterns of nasopharyngeal carcinoma. Eur Radiol 2007;17:2622-30. doi:10.1007/s00330-007-0616-z
  • 7. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook from the AJCC cancer staging manual. 6th ed. New York, Springer: 2002.

Nazofarenks kanserinin mastoid bölge rekürrensi: Nadir bir klinik tablonun tedavisi

Yıl 2014, Cilt: 27 Sayı: 2, 129 - 131, 20.05.2014

Öz

Nazofarenks kanserinde mastoid rekürrens takipte nadir izlenen bir
durumdur. Bu makale definitif tedavi sonrası izlenen izole mastoid
nüksünü sunmakta ve tedavisini tartışmaktadır. 

Kaynakça

  • 1. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012;22:233-44. doi:10.1016/j. semradonc.2012.03.008
  • 2. Atasoy BM, Ozyar E, Akman F, Esassolak M, Abacioğlu U. T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology? Kulak Burun Bogaz Ihtis Derg 2010;20:89-96.
  • 3. Atasoy BM, Dane F, Yumuk PF, et al. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma. J BUON 2008;13:43-50.
  • 4. Zhang X, Luo J, Gao L, Xu G. Mastoid recurrence after radiotherapy for nasopharyngeal carcinoma: two case studies. Head Neck 2011;33:1535-8. doi: 10.1002/hed.21391
  • 5. Yang MS, Chen CC, Cheng YY, et al. Nasopharyngeal carcinoma spreading along the eustachian tube: the imaging appearance. J Chin Med Assoc 2004;67:200-3.
  • 6. Dubrulle F, Souillard R, Hermans R. Extension patterns of nasopharyngeal carcinoma. Eur Radiol 2007;17:2622-30. doi:10.1007/s00330-007-0616-z
  • 7. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook from the AJCC cancer staging manual. 6th ed. New York, Springer: 2002.
Toplam 7 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Klinik Tıp Bilimleri
Bölüm Case Reports
Yazarlar

Ayşegül Üçüncü Kefeli Bu kişi benim

Beste Melek Atasoy

Zerrin Özgen Bu kişi benim

Murat Sarı Bu kişi benim

Fuat Dede Bu kişi benim

Faysal Dane Bu kişi benim

Yayımlanma Tarihi 20 Mayıs 2014
Yayımlandığı Sayı Yıl 2014 Cilt: 27 Sayı: 2

Kaynak Göster

APA Üçüncü Kefeli, A., Atasoy, B. M., Özgen, Z., Sarı, M., vd. (2014). Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Medical Journal, 27(2), 129-131.
AMA Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F. Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Med J. Mayıs 2014;27(2):129-131.
Chicago Üçüncü Kefeli, Ayşegül, Beste Melek Atasoy, Zerrin Özgen, Murat Sarı, Fuat Dede, ve Faysal Dane. “Recurrence of Nasopharyngeal Carcinoma in the Mastoid Region: Therapeutic Approach of a Rare Clinical Entity”. Marmara Medical Journal 27, sy. 2 (Mayıs 2014): 129-31.
EndNote Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F (01 Mayıs 2014) Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Medical Journal 27 2 129–131.
IEEE A. Üçüncü Kefeli, B. M. Atasoy, Z. Özgen, M. Sarı, F. Dede, ve F. Dane, “Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity”, Marmara Med J, c. 27, sy. 2, ss. 129–131, 2014.
ISNAD Üçüncü Kefeli, Ayşegül vd. “Recurrence of Nasopharyngeal Carcinoma in the Mastoid Region: Therapeutic Approach of a Rare Clinical Entity”. Marmara Medical Journal 27/2 (Mayıs 2014), 129-131.
JAMA Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F. Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Med J. 2014;27:129–131.
MLA Üçüncü Kefeli, Ayşegül vd. “Recurrence of Nasopharyngeal Carcinoma in the Mastoid Region: Therapeutic Approach of a Rare Clinical Entity”. Marmara Medical Journal, c. 27, sy. 2, 2014, ss. 129-31.
Vancouver Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F. Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Med J. 2014;27(2):129-31.